Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
131M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
43M
-
Shares change
-
-4.78M
-
Total reported value, excl. options
-
$952M
-
Value change
-
-$4.44M
-
Put/Call ratio
-
1
-
Number of buys
-
74
-
Number of sells
-
-81
-
Price
-
$22.13
Significant Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q3 2021
228 filings reported holding AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value as of Q3 2021.
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43M shares
of 131M outstanding shares and own 32.93% of the company stock.
Largest 10 shareholders include FMR LLC (9.34M shares), MORGAN STANLEY (6.7M shares), NEA Management Company, LLC (5.17M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (3.82M shares), PICTET ASSET MANAGEMENT SA (1.02M shares), Artal Group S.A. (1M shares), BlackRock Inc. (903K shares), KESTRA PRIVATE WEALTH SERVICES, LLC (801K shares), STIFEL FINANCIAL CORP (680K shares), and VOLORIDGE INVESTMENT MANAGEMENT, LLC (627K shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.